disorder
-
Sleep Health
Solriamfetol Shows Significant Promise in Treating Shift Work Disorder Among Early Morning Workers in New Clinical Trial
A groundbreaking clinical trial led by researchers at Mass General Brigham has demonstrated that solriamfetol, a wake-promoting medication, significantly improves…
Read More » -
Sleep Health
NightWare Secures Strategic Series C Investment from Exit 156 Capital to Scale FDA-Cleared Digital Therapeutic for PTSD-Related Nightmare Disorder
NightWare Inc., a pioneer in the digital therapeutics sector, has entered into a strategic partnership with Exit 156 Capital, marking…
Read More » -
Sleep Health
Breakthrough Clinical Trial Finds Solriamfetol Enhances Alertness and Safety for Early Morning Shift Workers Facing Shift Work Disorder
A pioneering clinical trial led by investigators at Mass General Brigham has demonstrated that solriamfetol, a wake-promoting medication currently marketed…
Read More »
